Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia

Clinical trial NCT04010968 · COMPLETED

Trial details

NCT number: NCT04010968
Sponsor: French Innovative Leukemia Organisation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intermediate Risk Chronic Lymphocytic Leukemia Fit Patients Risk-Adapted and MRD-Driven Strategy

Start date: 2019-09-27
Primary completion: 2023-04-03
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.